CN107557333A - 一种用于细胞治疗的新抗原呈递细胞的制备方法 - Google Patents
一种用于细胞治疗的新抗原呈递细胞的制备方法 Download PDFInfo
- Publication number
- CN107557333A CN107557333A CN201710958123.XA CN201710958123A CN107557333A CN 107557333 A CN107557333 A CN 107557333A CN 201710958123 A CN201710958123 A CN 201710958123A CN 107557333 A CN107557333 A CN 107557333A
- Authority
- CN
- China
- Prior art keywords
- cell
- preparation
- neoantigen
- antigen
- rpmi
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710958123.XA CN107557333B (zh) | 2017-10-16 | 2017-10-16 | 一种用于细胞治疗的新抗原呈递细胞的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710958123.XA CN107557333B (zh) | 2017-10-16 | 2017-10-16 | 一种用于细胞治疗的新抗原呈递细胞的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN107557333A true CN107557333A (zh) | 2018-01-09 |
CN107557333B CN107557333B (zh) | 2018-07-31 |
Family
ID=60986056
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710958123.XA Active CN107557333B (zh) | 2017-10-16 | 2017-10-16 | 一种用于细胞治疗的新抗原呈递细胞的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107557333B (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109294997A (zh) * | 2018-09-30 | 2019-02-01 | 北京鼎成肽源生物技术有限公司 | 一种lrfft1细胞 |
CN109295106A (zh) * | 2018-09-30 | 2019-02-01 | 北京鼎成肽源生物技术有限公司 | 一种hafft1细胞 |
CN110129371A (zh) * | 2018-09-30 | 2019-08-16 | 北京鼎成肽源生物技术有限公司 | 一种rfft2细胞的构建方法 |
CN110129372A (zh) * | 2018-09-30 | 2019-08-16 | 北京鼎成肽源生物技术有限公司 | 一种rfft1细胞的构建方法 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003089629A1 (en) * | 2002-04-19 | 2003-10-30 | I.D.M. Immuno-Designed Molecules | Rapid generation of activated mononuclear antigen presenting cells from monocytes |
CN1537161A (zh) * | 2001-07-30 | 2004-10-13 | ϣ��������ҩ��ҵ��˾ | 抗原呈递细胞、其制备方法及其用于癌症疫苗的用途 |
CN103301449A (zh) * | 2012-11-02 | 2013-09-18 | 泰州市数康生物技术有限公司 | 一种大规模培养树突状细胞疫苗的制备方法及其应用 |
US20150299320A1 (en) * | 2000-06-19 | 2015-10-22 | Beth Israel Deaconess Medical Center, Inc. | Compositions and methods of monoclonal and polyclonal antibodies specific for t cell subpopulations |
CN105112369A (zh) * | 2015-08-25 | 2015-12-02 | 北京康爱瑞浩生物科技股份有限公司 | 具有持续抗肿瘤活性的ctl细胞制剂及其制备方法 |
WO2017117418A1 (en) * | 2015-12-30 | 2017-07-06 | Anthrogenesis Corporation | T lymphocyte production methods and t lymphocytes produced thereby |
-
2017
- 2017-10-16 CN CN201710958123.XA patent/CN107557333B/zh active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20150299320A1 (en) * | 2000-06-19 | 2015-10-22 | Beth Israel Deaconess Medical Center, Inc. | Compositions and methods of monoclonal and polyclonal antibodies specific for t cell subpopulations |
CN1537161A (zh) * | 2001-07-30 | 2004-10-13 | ϣ��������ҩ��ҵ��˾ | 抗原呈递细胞、其制备方法及其用于癌症疫苗的用途 |
WO2003089629A1 (en) * | 2002-04-19 | 2003-10-30 | I.D.M. Immuno-Designed Molecules | Rapid generation of activated mononuclear antigen presenting cells from monocytes |
CN103301449A (zh) * | 2012-11-02 | 2013-09-18 | 泰州市数康生物技术有限公司 | 一种大规模培养树突状细胞疫苗的制备方法及其应用 |
CN105112369A (zh) * | 2015-08-25 | 2015-12-02 | 北京康爱瑞浩生物科技股份有限公司 | 具有持续抗肿瘤活性的ctl细胞制剂及其制备方法 |
WO2017117418A1 (en) * | 2015-12-30 | 2017-07-06 | Anthrogenesis Corporation | T lymphocyte production methods and t lymphocytes produced thereby |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109294997A (zh) * | 2018-09-30 | 2019-02-01 | 北京鼎成肽源生物技术有限公司 | 一种lrfft1细胞 |
CN109295106A (zh) * | 2018-09-30 | 2019-02-01 | 北京鼎成肽源生物技术有限公司 | 一种hafft1细胞 |
CN110129371A (zh) * | 2018-09-30 | 2019-08-16 | 北京鼎成肽源生物技术有限公司 | 一种rfft2细胞的构建方法 |
CN110129372A (zh) * | 2018-09-30 | 2019-08-16 | 北京鼎成肽源生物技术有限公司 | 一种rfft1细胞的构建方法 |
WO2020062795A1 (zh) * | 2018-09-30 | 2020-04-02 | 北京鼎成肽源生物技术有限公司 | 一种hafft1细胞 |
CN110129371B (zh) * | 2018-09-30 | 2021-03-16 | 北京鼎成肽源生物技术有限公司 | 一种rfft2细胞的构建方法 |
CN110129372B (zh) * | 2018-09-30 | 2021-06-18 | 北京鼎成肽源生物技术有限公司 | 一种rfft1细胞的构建方法 |
Also Published As
Publication number | Publication date |
---|---|
CN107557333B (zh) | 2018-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107557333B (zh) | 一种用于细胞治疗的新抗原呈递细胞的制备方法 | |
JP4157967B2 (ja) | 酵母系搬送媒介物 | |
US10159729B2 (en) | Antigen and method for production thereof | |
CN105754990A (zh) | 一种pd-1/ctla-4双特异性抗体的制备方法及其应用 | |
CN101824400B (zh) | 一种放大增殖抗原特异性t细胞的方法 | |
US11154571B2 (en) | Exosomes sourced from granulocytic myeloid-derived suppressor cells and application thereof | |
CN103071151A (zh) | 猪支原体肺炎疫苗专用稀释剂及其制备方法 | |
Yu et al. | Broad influenza-specific CD8+ T-cell responses in humanized mice vaccinated with influenza virus vaccines | |
Posch et al. | Antibodies attenuate the capacity of dendritic cells to stimulate HIV-specific cytotoxic T lymphocytes | |
Sun et al. | Dendritic cell-targeted recombinantLactobacilli induce DC activation and elicit specific immune responses against G57 genotype of avian H9N2 influenza virus infection | |
US10912798B2 (en) | Methods for treating an infectious or neoplastic disease | |
US9895432B2 (en) | Compositions, methods and therapies for administering antigen peptide | |
CN105709221A (zh) | 用于预防和/或治疗人中的hiv疾病的药物组合物 | |
CN110272874A (zh) | 一种包含负载新抗原的b细胞疫苗的免疫细胞药物 | |
WO2016095812A1 (zh) | 人工多抗原融合蛋白及其制备和应用 | |
CN106397574A (zh) | 抗原表位肽及其应用 | |
Teixeira et al. | Propionibacterium acnes enhances the immunogenicity of HIVBr18 human immunodeficiency virus-1 vaccine | |
US20080019972A1 (en) | Method for Amplifying Therapeutic Vaccine Activity | |
CN102228698B (zh) | Hpv58型治疗性复合基因疫苗及其构建方法 | |
RU2207876C1 (ru) | Способ комплексно-индивидуализированного воздействия на организм при медленной вирусной инфекции и способ подготовки лабораторного животного для испытания способа такого воздействия | |
JP2015504423A (ja) | 腫瘍免疫療法のためのワクチン | |
WO2021032179A1 (zh) | 铜绿假单胞菌疫苗在抗烧烫伤感染中的应用 | |
CN111057683A (zh) | 一种鸡胚接种用病毒稀释液及其制备方法和应用 | |
Johnson et al. | The Regulation of Nucleic Acid Vaccine Responses by the Microbiome | |
CN107254440A (zh) | Cd4阳性th17t细胞培养方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20181105 Address after: 102206 Room 101, 7 building, 20 Life Science Garden Road, Huilongguan, Changping District, Beijing. Co-patentee after: Jiao Shunchang Patentee after: BEIJING DINGCHENG TAIYUAN BIOTECHNOLOGY CO., LTD. Address before: 102206 room 316-26, B block 1, 29 life Garden Road, Changping District, Beijing. Patentee before: BEIJING DINGCHENG TAIYUAN BIOTECHNOLOGY CO., LTD. |
|
TR01 | Transfer of patent right | ||
CB03 | Change of inventor or designer information |
Inventor after: Jiao Shunchang Inventor after: Zhang Rong Inventor after: Zhang Tianfu Inventor before: Zhang Rong Inventor before: Zhang Tianfu |
|
CB03 | Change of inventor or designer information |